Advertisement
Research ArticleArticle

Pharmacological Characterization of [3H]VUF11211, a Novel Radiolabeled Small-Molecule Inverse Agonist for the Chemokine Receptor CXCR3

Danny J. Scholten, Maikel Wijtmans, Jeffrey R. van Senten, Hans Custers, Ailas Stunnenberg, Iwan J. P. de Esch, Martine J. Smit and Rob Leurs
Molecular Pharmacology April 2015, 87 (4) 639-648; DOI: https://doi.org/10.1124/mol.114.095265

Article Information

vol. 87 no. 4 639-648
DOI 
https://doi.org/10.1124/mol.114.095265
PubMed 
25576486
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received August 11, 2014
  • Accepted January 16, 2015
  • Published online February 23, 2015.

Article Versions

Copyright & Usage 
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Danny J. Scholten,
  2. Maikel Wijtmans,
  3. Jeffrey R. van Senten,
  4. Hans Custers,
  5. Ailas Stunnenberg,
  6. Iwan J. P. de Esch,
  7. Martine J. Smit, and
  8. Rob Leurs
  1. Amsterdam Institute for Molecules Medicines and Systems, Division of Medicinal Chemistry, Faculty of Science, VU University Amsterdam, Amsterdam, The Netherlands
  1. Address correspondence to:
    Dr. Rob Leurs, Amsterdam Institute for Molecules, Medicines and Systems, Division of Medicinal Chemistry, Faculty of Science, VU University Amsterdam, De Boelelaan 1083, 1081 HV, Amsterdam, The Netherlands. E-mail: r.leurs{at}vu.nl
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 2015 to September 2024

AbstractFullPdf
Jan 2015193291
Feb 20151541041
Mar 20153261229
Apr 20151111524
May 201558716
Jun 2015531415
Jul 2015471215
Aug 2015381014
Sep 20153736
Oct 201520137
Nov 20157168
Dec 20152548
Jan 20161058
Feb 20161476
Mar 2016441013
Apr 20161067
May 2016141013
Jun 2016251323
Jul 2016151029
Aug 201634718
Sep 2016211629
Oct 201601411
Nov 201611210
Dec 20161196
Jan 20171148
Feb 201731412
Mar 201773119
Apr 201711413
May 20172146
Jun 20172175
Jul 20173259
Aug 20174188
Sep 201753916
Oct 201753315
Nov 201744127
Dec 20173347
Jan 201843013
Feb 201851818
Mar 201813023
Apr 201822810
May 201832413
Jun 201844114
Jul 201852226
Aug 201811614
Sep 20180225
Oct 201802517
Nov 201802522
Dec 201811814
Jan 201922115
Feb 20191169
Mar 201901711
Apr 20190127
May 201922316
Jun 201932224
Jul 201902516
Aug 20190187
Sep 20192148
Oct 201901710
Nov 201921112
Dec 201912215
Jan 202011412
Feb 20200117
Mar 20201113
Apr 2020092
May 20202125
Jun 202011610
Jul 20201102
Aug 20201513
Sep 2020345
Oct 202012113
Nov 202051717
Dec 202061112
Jan 202141510
Feb 202191011
Mar 20215120
Apr 202124253
May 20214132
Jun 20211620
Jul 20211412
Aug 20211312
Sep 20211241
Oct 20213022
Nov 20212141
Dec 20211512
Jan 20221821
Feb 20222612
Mar 20221741
Apr 20222713
May 20221141
Jun 20223215
Jul 20221724
Aug 20221347
Sep 202210822
Oct 202216834
Nov 20223204
Dec 20221624
Jan 2023710
Feb 20231811
Mar 20231423
Apr 20231326
May 2023913
Jun 20231333
Jul 20232828
Aug 20235416
Sep 202315515
Oct 20231064
Nov 20231627
Dec 20231920
Jan 20242231
Feb 20243521
Mar 20247744
Apr 20245352
May 20247432
Jun 20241022
Jul 20245353
Aug 20242938
Sep 20241512

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

[3H]VUF11211 as Allosteric Radioligand for CXCR3

Danny J. Scholten, Maikel Wijtmans, Jeffrey R. van Senten, Hans Custers, Ailas Stunnenberg, Iwan J. P. de Esch, Martine J. Smit and Rob Leurs
Molecular Pharmacology April 1, 2015, 87 (4) 639-648; DOI: https://doi.org/10.1124/mol.114.095265
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement